AbbVie has submitted a New Drug Application to the FDA for its investigational pan-genotypic regimen of glecaprevir/pibrentasvir for HCV. Eight studies have shown high SVR across all major genotypes in patients and other health conditions.
AbbVie submits NDA for investigational... - Hepatitis C Support
AbbVie submits NDA for investigational regimen for all HCV genotypes
Written by
HFIAdmin
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Treating myself holistically
I'm new here, i've.had hep c 35 years, treating myself with supplements
Wouldn't touch the...
Starting treatment for gen type 1a in new year, anyone has any experience
Hi all. I have had hep c for twenty years and was told at my last appointment that I was now...
Hep c and fed up
Hi everyone, I'm new here I have hep c genotype 1B. I got it through a needle from a tattoo, I've...
Given a second chance 🌞
I just wanted to share with everyone on here that i can now say that i'm cured of hep c.i found out...
Finished Mavyret Treatment
Hello everyone!I finished my treatment 2 weeks ago and my last labs show the virus is...
Mavyret treatment 
Recent Diagnosis
Please help me understand just diagnosed with hep c gen.type1
New generation drugs
Research or just statistics